Preparing for DEA Oversight and Interstate Cannabis Commerce: What the Uplistings Are Telling You
In June 2026, Trulieve became the first U.S. plant-touching cannabis company to trade on the New York Stock Exchange. Glass […]
Filed for DEA Registration? One of Your First Moves Should Be a Full DCC Compliance Audit
Short answer: If your California medical cannabis business filed for DEA registration under the new Schedule III pathway, the single
Buying or Selling a Cannabis Business After Rescheduling: What California Buyers and Sellers Need to Know
The April 2026 federal cannabis rescheduling order may become one of the most important legal developments for cannabis M&A in
Considering a New Entity for Federal Medical Cannabis Registration? 9 Things California Retailers Should Think Through
On May 18, 2026, the California Department of Cannabis Control published proposed emergency regulations (DCC-2026-03-E) allowing licensed cannabis retailers to
The 60-Day Clock is ticking. Should you wait to file a DEA registration application?
TLDR: Medical cannabis licensees should at least prepare to submit a DEA registration application within the sixty-day window. The 60-day federal cannabis registration
The 60-Day Clock is ticking. Should you wait to file a DEA registration application? Read Post »
California Retailers Can Now Hold Separate Adult-Use and Medicinal Cannabis Licenses Under Two Related Entities
Today the California Department of Cannabis Control released proposed emergency regulations that allow licensed cannabis retailers to split a combined
DEA Medical Marijuana Application: A Section-by-Section Guide
TL;DR: The DEA’s Medical Marijuana Dispensary Registration Portal at https://mmapplication.diversion.dea.gov/ presents an eight-section application under 21 C.F.R. § 1301.13(k). Several
DEA Medical Marijuana Application: A Section-by-Section Guide Read Post »
Is DEA Registration Mandatory For Medical Marijuana Companies After The Rescheduling Order? One Oklahoma Agency Says Yes for Manufacturers and Distributors
On May 8, 2026, the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control (“OBNDD”) issued a directive that may